- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 487/02 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups in which the condensed system contains two hetero rings
Patent holdings for IPC class C07D 487/02
Total number of patents in this class: 360
10-year publication summary
5
|
9
|
15
|
11
|
20
|
28
|
20
|
32
|
21
|
7
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Janssen Pharmaceutica N.V. | 3839 |
8 |
Merck Sharp & Dohme LLC | 3689 |
8 |
F. Hoffmann-La Roche AG | 7958 |
6 |
The Regents of the University of California | 18943 |
6 |
Incyte Corporation | 918 |
6 |
Merck Patent GmbH | 5909 |
5 |
Rohm and Haas Electronic Materials Korea Ltd. | 546 |
5 |
Clap Co., Ltd. | 86 |
5 |
Bristol-myers Squibb Company | 5080 |
4 |
Merck Sharp & Dohme Corp. | 2247 |
4 |
Amira Pharmaceuticals, Inc. | 70 |
4 |
Gilead Sciences, Inc. | 1879 |
4 |
The Hong Kong University of Science and Technology | 638 |
4 |
Novartis AG | 11238 |
3 |
Hoffmann-La Roche Inc. | 3060 |
3 |
BASF SE | 19740 |
3 |
Genentech, Inc. | 3742 |
3 |
Pfizer Inc. | 3322 |
3 |
Amgen Inc. | 3779 |
3 |
Bioversys AG | 57 |
3 |
Other owners | 270 |